Cheap yet after nearly 100% gains? Oscar Health Stock can continue higher (NYSE: OSCR)

Cheap yet after nearly 100% gains? Oscar Health Stock can continue higher (NYSE: OSCR)

This article was written to

James Foord is an economist by trading and analysis of the world markets in the last decade. He led the investment group Progmatic invests Where the focus is to build strong and genuine different portfolios that continue to preserve and increase wealth.

Progmatic Inspy contains global macro, international equities, commodities, tech and cryptocurrencies and designed to lead investors on their journey. Parts include a progmatic investor portfolio, weekly market updates newsletter, actionable trades, technical analysis, and a chat room. Learn more.

Expression of analyst:I / we have a useful high position in oscr parts either by possession of stock, option, or other derivatives. I wrote this article on my own, and I expressed my own opinions. I am not receiving payment for it (other than finding alpha). I have no business relationship with any company that the stock is discussed in this article.

PLEASE PROVIDE ALPHA: Past performance does not guarantee future results. There is no recommendation or advice given if any investment is suitable for a particular investor. Any views or opinions stated above may not appear to find alpha altogether. Alpha search is not a licensed defensive dealer, investor or investor in US or Investment Bank investment. Our analysts are the third party authors who include professionals investors and individual investors who may not be licensed or certified by any body of the Institute or Regulation.

Leave a Reply

Your email address will not be published. Required fields are marked *